Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. Why did this happen? For more information you can review our Terms of Service and Cookie Policy. Mavacamten is being developed to treat obstructive and non-obstructive forms of a condition called hypertrophic cardiomyopathy - estimated to affect one in every 500 people globally. Mavacamten is being developed to treat obstructive and non-obstructive forms of a condition called hypertrophic cardiomyopathy - estimated to affect one in every 500 people globally.
Mavacam is being developed to treat spices and fruits.
( z0 develop :ARG1 ( z1 product :name ( z2 name :op "Mavacam" ) ) :ARG3 ( z3 treat :ARG1 ( z4 and :op ( z5 nut ) :op ( z6 fruit ) ) :ARG2 z1 ) )
(z0 / develop-02
    :ARG1 (z1 / product
              :name (z2 / name
                        :op1 "Mavacam"))
    :ARG3 (z3 / treat-03
              :ARG1 (z4 / and
                        :op1 (z5 / nut)
                        :op2 (z6 / fruit))
              :ARG2 z1))
Mavacam is being developed to treat spices and fruits .
z1 :name z2
z2 :op1 0
z0 :ARG1 z1
z0 :ARG3 z3
z3 :ARG2 z1
z4 :op1 z5
z3 :ARG1 z4
z4 :op2 z6